Rare diseases
Investigational molecules
Locations
103 Grande Rue De La Croix Rousse, 69317 Lyon, France
CHU Croix Rousse-Lyon in Lyon, France specialises in clinical trials of conditions such as Metabolic dysfunction-associated steatohepatitis, Asthma, Hepatocellular carcinoma, Chronic obstructive pulmonary disease, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in ear, nose, and throat diseases, focusing on innovative treatments and improving patient outcomes. The center's commitment to advancing the field is evident through its exploration of novel therapeutic approaches.
By conducting multicenter randomized controlled trials, the center contributes significantly to the understanding and management of complex ENT conditions, enhancing the quality of life for patients through targeted interventions.
Clinical trials currently enrolling participants at this site.
Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
FranceA Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
FranceStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
FranceA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
FranceStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
FranceStudy on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
FranceStudy on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
FranceStudy on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)
FranceEvaluating the use of capecitabine, oxaliplatin, fluorouracil, folinic acid, and irinotecan to personalize chemotherapy for patients with stage III colorectal cancer
FranceA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
FranceA study of islatravir and ulonivirine for adults with HIV who have not received previous treatment
FranceFranceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
